RELIQ Study: Reduced levels of nicotine in cigarettes to increase quitting

Phase 3

Completed

• Conditions: Smoking Cessation; Public Health - Epidemiology

• Registration Number: ACTRN12608000410358
• Lead Sponsor: Heath Research Council NZ

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-08-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1410

Inclusion Criteria

1. they want to stop smoking
2. they are at least 18 years of age
3. their time to first cigarette is within 30 minutes of waking
4. they are able to provide verbal consent
5. they have access to a telephone

Exclusion Criteria

Pregnant and breastfeeding women and smokers who have had a heart attack, stroke, or unstable angina within the last two weeks will be excluded, as will smokers who are current users of NRT products, those who use only non-cigarette tobacco products (e.g. pipes, cigars), those who are currently using non nicotine-based cessation therapies (e.g. buproprion [Zyban], clonidine, nortriptyline, or varenicline [Champix]), and those who are current clients of Txt2Quit and NRT Online.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of participants who report 7-day point prevalence abstinence at six months since Quit date (biochemically verified)[6 months post quit date]

Secondary Outcome Measures

Name	Time	Method
Three week, six week and three month 7-day point prevalence abstinence rates since quit date.[three weeks, six weeks and three months since quit date.];Three and six month continuous abstinence rates since quit date, biochemically verified at 6 months[Three and six months since quit date]